The 5th International Workshop on CAR-T (iwCAR-T) took place in Scottsdale, AZ, on 14 – 16 April, 2023, and brought together world-leading experts in CAR-T therapy as they discussed the latest in the field. In this podcast series, you will gain an insight into the sessions that took place at this year’s meeting, which covered the latest updates in CAR-T therapy in chronic lymphocytic leukemia (CLL), lymphoma, acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and more.
In this podcast, you will hear from John Gribben, MD, DSc, FRCP, FRCPath, FMed Sci, Barts Cancer Institute, London, UK, Joseph Melenhorst, PhD, Cleveland Clinic, Cleveland, OH, and Tanya Siddiqi, MD, City of Hope, Duarte, CA, who discuss challenges with implementing CAR-T therapy in CLL, ongoing clinical trials, and research exploring combination approaches with CAR-T cells and Bruton’s tyrosine kinase (BTK) inhibitors.
The post iwCAR-T Session IV: CAR-T therapy in CLL: challenges, combination approaches and ongoing trials appeared first on VJHemOnc.
